Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues.
Total revenue declined 7% year-over-year to $2.30 billion in the March quarter. For the full year of 2024, the company expects revenues to decline in the low-to-mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen was $393.4 million or $2.70 per share in Q1, compared to $387.9 million or $2.67 per share in the prior-year period. Adjusted earnings moved up 8% annually to $3.67 per share in the first quarter.
Prior Performance
Most Popular
CRWD Earnings: CrowdStrike Q1 profit jumps on strong revenue growth
CrowdStrike Holdings, Inc. (NASDAQ: CRWD), a leading cybersecurity company, has reported strong earnings growth for the first quarter of 2025 when its revenues grew in double digits. April-quarter revenue increased
CPB Earnings: Key quarterly highlights from Campbell Soup’s Q3 2024 financial results
Campbell Soup Company (NYSE: CPB) reported third quarter 2024 earnings results today. Net sales increased 6% year-over-year to $2.36 billion. Organic sales remained flat. Net earnings attributable to Campbell Soup
HPE Earnings: Hewlett Packard Q2 profit drops but beats Street view
Information technology solutions provider Hewlett Packard Enterprise (NYSE: HPE) on Thursday reported a year-over-year decline in earnings for the second quarter of 2024. Earnings, however, topped expectations. April-quarter profit, excluding
